Targeted therapies in rheumatoid arthritis: the need for action

Abstract
Rheumatoid arthritis (RA) is a common, chronic, disabling disease with a significant morbidity and mortality; the reduction of life expectancy is estimated at up to 10 yr. The total cost of the disease has been calculated at over 1 billion pounds per annum in the UK.

This publication has 0 references indexed in Scilit: